Aled Paton Williams

Aled brings more than twenty-five years of leadership experience across pharma and biotech sectors.

Aled joined Enthera from Polyneuron Pharmaceuticals, where he served as Chief Business Officer. Prior to this, he served as Chief Commercial Officer at VectivBio. VectivBio was spun-out of Therachon (following the acquisition by Pfizer), where Aled also served as Chief Commercial Officer. Aled’s prior experience includes more than seven years at Shire, where he was Vice President and Global Strategy Head and led three of the rare disease therapeutic areas. Prior to Shire, Aled held leadership positions of increasing responsibility at Bristol-Myers Squibb, Novartis and Roche.

Aled originally trained in microbiology and started his career working in Public Health.